GLP-1 Drugs Linked to Higher Risk of Age-Related Macular Degeneration

General Medicine

People taking glucagon-like peptide-1 (GLP-1) receptor agonists had a higher risk of neovascular age-related macular degeneration (nAMD) in a retrospective study, which built on previous findings linking these medications to vision impairment.

Read Full Article

Journal Source :

JAMA - Journal of the American Medical Association

Sustain the Knowledge Stream!

For unrestricted access to content and a seamless experience,

Continue to Login

Don't have an account?

We’d love to get to know you better!

Complete your profile to help us deliver a more personalized experience.

Menu

GLP-1 Drugs Linked to Higher Risk of Age-Related Macular Degeneration

Journal Source :

Comments

Questions (1/5)

Q.1:

In your opinion, what might be the diagnosis for the 11-year-old girl described in the case?

Thank You!

You score is 60%.

Total Questions

Total Right Answer

Total Wrong Answer

Sustain the Knowledge Stream!

Continue to Login

Don't have an account?

We’d love to get to know you better!